Literature DB >> 21038716

Changing epidemiology of pneumococcal serotypes after introduction of conjugate vaccine: July 2010 report.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21038716

Source DB:  PubMed          Journal:  Wkly Epidemiol Rec        ISSN： 0049-8114


× No keyword cloud information.
  15 in total

1.  Cost-effectiveness analysis of pneumococcal polysaccharide vaccination from age 60 in São Paulo State, Brazil.

Authors:  Joao Tonolio Neto; Gabriela Tannus Branco de Araujo; Anna Gagliardi; Amanda Pinho; Laure Durand; Marcelo Fonseca
Journal:  Hum Vaccin       Date:  2011-10-01

2.  Changes in invasive pneumococcal disease serotypes in a regional area of Australia following three years of 7vPCV introduction.

Authors:  Tove Fitzgerald; Peter D Massey; Fakhrul Islam
Journal:  Western Pac Surveill Response J       Date:  2012-06-01

Review 3.  Preventing pneumococcal disease in the elderly: recent advances in vaccines and implications for clinical practice.

Authors:  Angel Vila-Corcoles; Olga Ochoa-Gondar
Journal:  Drugs Aging       Date:  2013-05       Impact factor: 3.923

4.  Assessment of health benefits and cost-effectiveness of 10-valent and 13-valent pneumococcal conjugate vaccination in Kenyan children.

Authors:  Philip Ayieko; Ulla K Griffiths; Moses Ndiritu; Jennifer Moisi; Isaac K Mugoya; Tatu Kamau; Mike English; J Anthony G Scott
Journal:  PLoS One       Date:  2013-06-24       Impact factor: 3.240

5.  Effect of pneumococcal conjugate vaccination on serotype-specific carriage and invasive disease in England: a cross-sectional study.

Authors:  Stefan Flasche; Albert Jan Van Hoek; Elizabeth Sheasby; Pauline Waight; Nick Andrews; Carmen Sheppard; Robert George; Elizabeth Miller
Journal:  PLoS Med       Date:  2011-04-05       Impact factor: 11.069

6.  7-Valent pneumococcal conjugate vaccination in England and Wales: is it still beneficial despite high levels of serotype replacement?

Authors:  Yoon Hong Choi; Mark Jit; Nigel Gay; Nick Andrews; Pauline A Waight; Alessia Melegaro; Robert George; Elizabeth Miller
Journal:  PLoS One       Date:  2011-10-14       Impact factor: 3.240

7.  The prevalence and risk factors for pneumococcal colonization of the nasopharynx among children in Kilifi District, Kenya.

Authors:  Osman Abdullahi; Angela Karani; Caroline C Tigoi; Daisy Mugo; Stella Kungu; Eva Wanjiru; Jane Jomo; Robert Musyimi; Marc Lipsitch; J Anthony G Scott
Journal:  PLoS One       Date:  2012-02-20       Impact factor: 3.240

8.  Rates of acquisition of pneumococcal colonization and transmission probabilities, by serotype, among newborn infants in Kilifi District, Kenya.

Authors:  Caroline C Tigoi; Hellen Gatakaa; Angela Karani; Daisy Mugo; Stella Kungu; Eva Wanjiru; Jane Jomo; Robert Musyimi; John Ojal; Nina E Glass; Osman Abdullahi; J Anthony G Scott
Journal:  Clin Infect Dis       Date:  2012-04-20       Impact factor: 9.079

9.  Monitoring the introduction of pneumococcal conjugate vaccines into West Africa: design and implementation of a population-based surveillance system.

Authors:  Grant A Mackenzie; Ian D Plumb; Sana Sambou; Debasish Saha; Uchendu Uchendu; Bolanle Akinsola; Usman N Ikumapayi; Ignatius Baldeh; Effua Usuf; Kebba Touray; Momodou Jasseh; Stephen R C Howie; Andre Wattiaux; Ellen Lee; Maria Deloria Knoll; Orin S Levine; Brian M Greenwood; Richard A Adegbola; Philip C Hill
Journal:  PLoS Med       Date:  2012-01-17       Impact factor: 11.069

10.  Serotype-specific changes in invasive pneumococcal disease after pneumococcal conjugate vaccine introduction: a pooled analysis of multiple surveillance sites.

Authors:  Daniel R Feikin; Eunice W Kagucia; Jennifer D Loo; Ruth Link-Gelles; Milo A Puhan; Thomas Cherian; Orin S Levine; Cynthia G Whitney; Katherine L O'Brien; Matthew R Moore
Journal:  PLoS Med       Date:  2013-09-24       Impact factor: 11.069
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.